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Adolescence and Preeclampsia
Sergio Rosales-Ortiz, Olivia Sánchez Rodríguez, 
Mario Borbolla-Ramos and Karen D. García-Pérez
Abstract
Adolescent pregnancy is defined as that which occurs in a woman between 10 
and 19 years of age. Approximately 10% of all women aged 15–19 become pregnant. 
It is estimated that 11% of births worldwide occur in this population. In teenage 
population, preeclampsia has a prevalence twice as high as that in adult population. 
Adolescent population is exposed to different maternal-fetal adverse outcomes 
such as preterm birth, low birth weight, and gestational diabetes mellitus, associ-
ated with the outcomes of preeclampsia like seizures, pulmonary edema, defects 
in coagulation, liver or kidney failure, and death. The risk of adverse outcome 
remained increased in adolescent compared to young adult mothers (20–24 years). 
That is why it’s important to know the approach of preeclampsia in adolescent preg-
nancy. We will describe the principal chance in the adolescent pregnancy, related 
risk factors, major complications for mother and fetus, and management and late 
complication for both.
Keywords: adolescent pregnancy, preeclampsia
1. Introduction
Pregnancy at any age constitutes a very important biopsychosocial event, but 
in adolescence it encompasses a series of situations that may place the mother’s and 
the fetus’ health at risk, thus becoming a public health issue not only in the present 
but also in the future due to potential complications and as a reflection of the social 
conditions of a country.
Maternal, late fetal, neonatal, and infant mortalities have the highest rates in 
women under 20 years of age than in any other reproductive period.
Complications in adolescent mothers are a constant dilemma since many factors 
are involved, such as inadequate prenatal control, race, family factors, and eco-
nomic and sociodemographic conditions.
Hypertensive problems associated with pregnancy are another public health 
issue that in developing countries still represent the first cause of maternal death; 
worldwide, their prevalence varies but hovers around 10% of all pregnancies.
Whatever causes triggering complications, maternal and neonatal deaths are 
significant indicators in all countries, and in the case of pregnant adolescents, 
developing preeclampsia and their high and varied worldwide prevalence make this 
combination, specifically this group of patients, a point of reference when estab-
lishing health policies.
Prediction of Maternal and Fetal Syndrome of Preeclampsia
2
2. Definition of adolescence
The WHO defines adolescence as the period of human growth and development 
after childhood and before adulthood, between the ages of 10 and 19. It is one of the 
most important transitional phases in human life, characterized by an accelerated 
rhythm of growth and changes, only surpassed by those in infants. This growth and 
development phase is conditioned by several biological processes. The beginning of 
puberty is the hallmark of passage from childhood to adolescence. From this stage 
on, the reproductive system’s capacity to procreate is potentially latent [1].
3. Classification of adolescence
It is difficult to establish the chronological boundaries of this period, but in 
accordance with conventionally accepted concepts accepted by the World Health 
Organization (WHO), adolescence may be divided into two phases:
1. Early (10–14 years).
2. Late (15–19 years).
Likewise, other authors refer that there are three stages:
1. Early adolescence, between the ages of 10 and 13.
2. Mid-adolescence, between the ages of 14 and 17.
3. Late adolescence, between the ages of 17 and 21 [2].
4. Impact of pregnancy on an adolescent
The beginning of sexual activity in adolescents currently occurs at a younger 
age and carries immediate unwanted consequences such as an increased frequency 
of sexually transmitted diseases (STD) and unwanted pregnancy that may lead to 
miscarriage or other complications during pregnancy [3].
From a biological viewpoint, some of the consequences of adolescent pregnancy 
include hypertensive disease of pregnancy, anemia, gestational diabetes, and com-
plications during childbirth that lead to an increase in maternal and fetal mortality 
[4]; complications in the newborn include higher rates of low birth weight, prema-
ture delivery, respiratory diseases, dystocia, and an increased frequency of neonatal 
complications and greater infant mortality [5].
Risk factors in adolescent pregnancy include low educational level, beginning 
sexual activity before the age of 15, absence of the partner, maternal history of 
pregnancy in adolescence, and the lack of knowledge and access to birth control 
methods. There is also a high percentage of school dropouts, a lack of plans for the 
future, low self-esteem, alcohol and drug abuse, ignorance on sexuality, and an 
inadequate use of birth control [6].
A correlation has been shown between minimal or absent family communication 
on birth control and sexuality and a higher risk of adolescent pregnancy and infec-
tion with sexually transmitted diseases [7].
Medical risks associated with pregnancy in adolescent mothers such as hyper-
tensive pathology, anemia, low birth weight, prematurity, insufficient nutrition, 
3Adolescence and Preeclampsia
DOI: http://dx.doi.org/10.5772/intechopen.86147
etc. lead to an increase in maternal morbidity and mortality and an estimated two- 
to threefold increase in infant mortality among patients in the age range between 20 
and 29.
In adolescents, the higher observed compared risk does not appear to be due to 
special physiologic conditions but to sociocultural variables and the medical care 
provided to these patients.
These pregnancies are frequently unwanted or unplanned events within a weak 
couple relationship, which leads to an attitude of rejection and concealment because 
of fear of the family group that, in turn, conditions late or insufficient prenatal care.
According to various publications, we must emphasize that 73–93% of cases 
of pregnant adolescents are women bearing their first child. The first pregnancy 
carries specific risks resulting from physiological immaturity in the pregnant 
<16 years >16 years
Kawakita [37] CS OR = 0.49;
CI 95% = 0.42–0.59
OR = 0.75;
CI 95% = 0.71–0.79
CA OR = 0.63;
CI 95% = 0.47–0.84
OR = 0.83;
CI 95% = 0.75–0.91
MA OR = 1.25;
CI 95% = 1.07–1.45
OR = 1.15;
CI 95% = 1.09–1.22
PD < 37 weeks OR = 1.36; CI 95% = 1.14–1.62 aOR = 1.16;
CI 95% = 1.08–1.25
PPH* and BT** *OR = 1.46;
CI 95% = 1.10–1.95
**OR = 1.21;
CI 95% = 1.02–1.43
Preeclampsia and 
HELLP Sd
OR = 1.44;
CI 95% = 1.17–1.77
PL OR = 0.82;
CI 95% = 0.71–0.95
Bostanci 
et al. [21]
Early 
adolescent 
(%)
Late 
adolescent 
(%)
Adult 
(%)
P value
Preeclampsia 4.8 2.7 5.9 <0.001
PD 37.2 12.8 2.2 <0.001
PPROM 37.2 10.2 8.5 <0.001
IUGR 9 3.3 5.4 <0.001
Postterm 0.7 5.9 8.7 <0.001
Episiotomy 79.3 69.8 70 >0.05
NICU 18 11.7 10 0.009
Neonatal outcome 2.1 1.1 2.1 >0.05
LBW 17.9 13.2 13.1 >0.05
VLBW 4.1 3.4 2.7 >0.05
CS 17.2 25.7 29.6 0.001
CS, cesarean section; CA, chorioamnionitis; MA, maternal anemia; PD, preterm delivery; PPH, postpartum 
hemorrhage; BT, blood transfusion; PL, perineal laceration; PPROM, preterm premature rupture of membranes; 
IUGR, intrauterine growth restriction; NICU, neonatal intensive care unit admission; LBW, low birth weight; 
VLBW, very low birth weight.
Table 1. 
Comparison of some pregnancy complications and outcome among early and late adolescent.
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adolescent. For example, preeclampsia or gestation-induced hypertension is more 
frequent in young pregnant women, from a low socioeconomic level, and specifi-
cally, in the first pregnancy, conditions all frequently met by a pregnant adolescent. 
When developing this clinical entity, a possible failure in the adaptive immune 
response has been posited, although it normally permits the development of a close 
interrelation between the maternal organism and its host. Since 50% of the fetal 
antigenic structure is of paternal origin, it acts like a graft and has been associated 
to factors such as immaturity of the maternal immune system or a functional abnor-
mality that may be associated to maternal malnutrition, a very common condition 
in pregnant adolescents. Morbidity may be classified according to the gestational 
periods, whereby miscarriage, anemia, urinary tract infections, and asymptom-
atic bacteriuria are more common in the first half. In the second half, there are 
hypertensive manifestations, hemorrhage associated to placental pathology, scarce 
weight gain and associated maternal malnutrition, symptoms of premature delivery 
(abnormal contractility), and premature membrane rupture [8, 9].
Several authors have suggested that there is a relation between hypertensive 
disorders and pregnancy, which will be further discussed in this chapter. Other 
complications are summarized in Table 1.
A strategy to confront these problems and adolescent pregnancy is to increase the 
availability of high-quality sexual and reproductive health services for adolescents [10].
5. Frequency of preeclampsia in adolescents
Preeclampsia refers to a relatively common hypertensive disorder during preg-
nancy that develops progressively. Its cause remains unknown, and it frequently 
leads to severe maternal and perinatal complications.
Its incidence is broad since it depends on various aspects such as geographic loca-
tion, race, nutritional or immunological factors, and associated comorbidities, and even 
a humid and cold climate has been related to a higher incidence of affected women.
It is estimated that about 7% of pregnancies will develop preeclampsia. The inci-
dence of preeclampsia is about 25% in primiparous women. In industrialized nations, 
the rate of maternal morbidity due to preeclampsia varies between 3.8 and 12 per 1000 
births. In Latin America, there are few reports on the subject, so the real magnitude of 
the problem remains unknown; there are only some studies from Brazil and Cuba [11].
Throughout the world, 25% of all maternal deaths occur in adolescent women. 
In Latin America, adolescent pregnancy is an independently associated factor 
conferring greater risk for adversities during pregnancy [12, 13]. In the United 
States, the maternal mortality rate due to preeclampsia-eclampsia is approximately 
1 for every 100,000 live births. In Mexico, maternal mortality has decreased in the 
past six decades, whereby 1281 maternal deaths were registered in the year 2009, in 
women between the ages of 15 and 34 [14].
The main causes of death in pregnant women were:
1. Hypertensive disease induced by pregnancy (20.4%).
2. Obstetric hemorrhage (19%).
3. Sepsis (4.1%).
These percentages are five to ten times greater than those reported in industrial-
ized nations or in those with more developed national health systems [15, 16].
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6. Definitions of hypertensive states in pregnancy
According to the American College of Obstetricians and Gynecologists (ACOG) 
[17–19], the classification of hypertensive disorders in pregnancy is as follows:
Hypertensive disease induced by pregnancy:
• Preeclampsia
 ○ Mild
 ○ Severe
• Eclampsia
Chronic hypertension before pregnancy (any etiology).
Chronic hypertension and pregnancy-induced hypertension:
• Preeclampsia
• Eclampsia
6.1 Pregnancy-induced hypertensive disorders
Pregnancy-induced hypertension (PIH) is defined as the disorder that develops 
during gestation, delivery, or postpartum, characterized by elevated blood pres-
sure values ≥140/90 mm Hg, accompanied by signs and symptoms allowing it to be 
classified according to its severity.
6.2 Preeclampsia
Preeclampsia refers to the presence of hypertension with values above those 
previously mentioned and proteinuria, in a pregnant female after the 20th week, 
after excluding hydatidiform mole or hydrops fetalis.
Arterial hypertension (AH) is diagnosed if the obtained values exceed, on 
two separate occasions and with at least 6 hours between each measurement, 
140/90 mm Hg or if there is an increase in systolic arterial pressure (SAP) of 
at least 30 mm Hg or an increase in diastolic arterial pressure (DAP) of at least 
15 mm Hg.
Proteinuria can be diagnosed with a urine test strip but must be confirmed with 
a quantitative method (urine sample or 24-hour urine).
Proteinuria must be above >300 mg in the urine collected in 24 hours or the 
protein: creatinine ratio must be ≥0.3.
6.3 Severe preeclampsia
Severe preeclampsia is defined as a systolic BP ≥160 mm Hg and/or a diastolic BP 
≥110 mm Hg, if detected on two separate occasions, with a 6-hour difference, with 
proteinuria greater than 5 g/24 hours and no previous history of arterial hyperten-
sion, diabetic nephropathy, or renal disease.
HELLP syndrome is the acronym of hemolysis, elevated liver enzyme levels, and 
low platelet levels; this syndrome occurs in 10–20% of women with preeclampsia or 
eclampsia and is considered a severe form of the disease since it leads to increased 
mortality.
Prediction of Maternal and Fetal Syndrome of Preeclampsia
6
6.4 Eclampsia
It is defined as the presence of seizures or coma in a patient with preeclampsia, 
and that cannot be explained by another underlying cause.
6.5 Chronic hypertension
BP > 140/90 mm Hg before pregnancy or the same obtained values on two 
separate occasions prior to week 20 of gestation or persistent hypertension after the 
sixth week postpartum.
6.6 Chronic hypertension and pregnancy-induced hypertension
It is defined as an increase in SAP greater than 30 mm Hg or an increase greater 
than 15 mm Hg in DAP, on two separate occasions, prior to week 20 of gestation, 
initial proteinuria, and generalized edema.
6.7 Transient or late arterial hypertension
This is hypertension developing in the postpartum without previous preeclamp-
sia; values return to baseline after the tenth day postpartum.
7. Physiopathology of preeclampsia
Preeclampsia is a syndrome that compromises all maternal organs and systems.
The etiology of hypertensive disorders in pregnancy remains to be identified 
since searching for their origin has led to an infinite number of hypotheses that 
encompass practically all maternal and fetal organs.
Its physiopathology has not been totally elucidated, and it is no different in the 
adolescent patient than in the rest of the affected population.
Several factors have been implicated in its physiopathology such as oxidative 
stress, the inflammatory response, abnormal circulatory adaptation, metabolic 
abnormalities, and even abnormalities in placental development, releasing circu-
lating factors that interfere with vascular endothelial growth factor (VEGF) and 
placental growth factor (PGF).
Aside from the physiopathogenic factors to be discussed ahead, many factors 
predisposing to preeclampsia have been reported, such as extreme ages (very young 
or older), nulliparity, obesity, smoking, a history of preeclampsia in a previous 
pregnancy, etc. Other less studied factors include some infections, asthma, and the 
time period between pregnancies [20].
7.1 Systemic endothelial dysfunction
Endothelial abnormality leads to dysfunction in the control of muscle tone in 
blood vessels which, in turn, may cause hypertension, edema due to increased 
permeability, and also proteinuria.
Likewise, the abnormal expression of procoagulant factors by the endothelium 
favors the development of coagulopathy. All of these abnormalities injure target 
organs such as the kidney, the liver, the central nervous system, and the placenta. 
Women with previous vascular disease are at greater risk of developing preeclamp-
sia, quite possibly a result of preestablished vascular injury.
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7.1.1 First phase: abnormal placentation and placental ischemia
The placenta plays a pivotal role in the development of preeclampsia since it only 
develops in its presence and symptoms rapidly remit after delivery.
During the development of normal placentation, the cytotrophoblast invades 
the spiral arteries which leads to their remodeling; they will have low resistance 
and high elasticity or capacitance. This cytotrophoblastic vascular invasion not 
only affects the most superficial layers but reaches the muscle tunica. Trophoblast 
penetration has also been reported as incomplete and is not invasive in patients with 
preeclampsia; after complete remodeling of the spiral arteries, placental perfusion 
decreases. Although remodeling of the spiral arteries begins in the first trimester, it 
is not considered complete until weeks 18–20 of gestation.
Recently, great importance has been attributed to angiogenesis because of 
molecules such as VEGF, angiopectin, and other proteins in the ephrin family. The 
invasive trophoblast expresses VEGF, P1GF, VEGF, and their respective receptors. 
Likewise, in in vitro studies in which these signals were blocked, integrin alpha-1, a 
marker of pseudovasculogenesis, decreased alarmingly.
7.1.2 Second phase: systemic endothelial dysfunction
As previously mentioned, systemic endothelial dysfunction in these patients may 
explain all or almost all of the clinical signs, such as hypertension, proteinuria, or abnor-
malities in target organs such as the liver, the central nervous system, or the kidneys.
Among the various findings upholding this theory, we can mention the 
following:
• The plasma elevation in some biomarkers, such as fibronectin, factor VIII, and 
thrombomodulin, reflects endothelial cell injury in patients with preeclampsia.
• Vasodilation mediated by flow has also been reported in the vessels of women 
with preeclampsia, suggesting altered endothelial function.
• Decreased production of vasodilators such as prostacyclins or an increase in 
the production of angiotensin II also suggests endothelial injury.
• In these patients, renal biopsies show diffuse glomerular injury caused by 
glomerular endotheliosis.
• Likewise, the serum of women with preeclampsia has been shown to activate the 
endothelium in in vitro studies using endothelial cells from the umbilical veins.
An important factor for future consideration is that the increased concentrations 
of sFlt-1 generally precede, by 5 weeks, the development of clinical manifestations 
and appear to be most elevated in the initial phase of severe preeclampsia. However, 
neither PlGF nor VEGF, measured during gestation, appears to decrease prior to the 
onset of preeclampsia symptoms.
Most recently, decreases in urinary PIGF have been described before the devel-
opment of preeclampsia. Some authors have speculated that sFlt-1 plays a beneficial 
role in fetal circulation and that preeclampsia is a reflection of a maladaptive effect 
of its release into the maternal circulation. Thus, in the setting of some spiral 
arterioles with increased resistance, vasoconstriction of the nonplacental maternal 
circulation would theoretically increase the cardiac output percentage reaching the 
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placental sub-circulation. Although most cases of preeclampsia are sporadic, some 
authors suggest that genetics play a role in the development of this entity based on a 
series of findings:
• Primiparous women with a positive family history of preeclampsia have a two- 
to fivefold greater risk of developing preeclampsia than primiparous women 
without this history.
• In sisters with preeclampsia, the genetic imprint plays a major role in the 
development of the disease.
• Studies in women pregnant with males that were the result of a gestation with pre-
eclampsia have greater probabilities of developing the disease in their pregnancies.
• Women who became pregnant with men whose previous partner had pre-
eclampsia have greater probabilities of developing the disease if gestation with 
the previous partner was normotensive [20].
7.2 Preeclampsia-eclampsia in adolescents
Traditional references accept that the risk of preeclampsia-eclampsia in 
adolescents is twice that in the adult population. However, literature reviews are 
contradictory; while one group of authors refer to an increased risk of preeclampsia 
in adolescents [21], others detect no differences between these and adult pregnant 
women, as shown in Table 2.
Several studies and meta-analysis [22] detect a significant difference between 
pregnant adolescents and adult women, with up to 20% more preeclampsia events 
in pregnant adolescents than in adult women [23]; they actually report a greater risk 
of preeclampsia-eclapmsia in the group of adolescents between the ages of 13 and 
16 when compared with women between the ages of 20 and 34, OR 2.97 (95%CI 
1.62–5.42) [24], as well as lower frequencies of preeclampsia in adolescents (5%) 
vs. 1.5% in the adult group, and the difference was statistically significant, OR 3.66 
(95%CI 1.67–7.72) [25].
Therefore, the frequency of preeclampsia in adolescents is currently different 
according to the studied population as a result of many factors such as prenatal care 
and body weight changes in pregnancy [26–29].
There is significant bias in observational studies that depend on the type of 
design and case identification; in these cases, no significant association is found 
suggesting an increased frequency of preeclampsia in pregnant adolescents, RR 
0.88 (95%CI 95% 0.73–1.23). On the contrary, if we take into account follow-up 
studies, the pregnant adolescent is 23% less likely to develop preeclampsia when 
compared with pregnant women in other age ranges, RR 0.77 (95%CI 0.64–0.92).
Therefore, the available evidence suggests that adolescence is not a determining 
factor in the development of preeclampsia and eclampsia, but geographic area does 
appear to be an additional factor.
In a systematic review [30] describing pregnant adolescents that participated 
in integral prenatal care programs, they had a lower risk of developing pregnancy-
induced hypertension (RR 0.59) than those following traditional prenatal care 
programs. This means that integral prenatal care programs focused on adolescents 
decrease the frequency of pregnancy-induced pregnancy by 41% [10].
Due to the heterogeneous presentations of preeclampsia in adolescents from 
different regions, age is probably not a determining factor but is rather associated to 
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other variables, such as excess weight, excessive weight gain during pregnancy, and 
inadequate prenatal care, among others.
Two factors warrant analysis in terms of the development of preeclampsia in 
pregnant adolescents; the first is its association with obesity. Obesity is currently con-
sidered an epidemic in which one of every four women in reproductive age is obese 
and over half of women between the ages of 20 and 39 have excess weight or obesity. 
Obesity has been reported to increase the risk of adverse maternofetal outcomes due 
to its association to and development of comorbidities such as gestational diabetes, 
fetal macrosomia, an increase in cesarean sections, and preeclampsia. Its genesis is 
the increase in oxidative stress; an increase in circulating pro-inflammatory bio-
markers such as C-reactive protein, tumor necrosis factor-alpha, interleukin-6, and 
interleukin-8; the presence of dyslipidemia, insulin resistance, and abnormalities of 
endothelial function, all playing a role in the pathogenesis of preeclampsia [31].
Another factor leading to a poor maternal-perinatal outcome and that also 
increases the risk of preeclampsia is an inadequate nutrient intake, including 
calcium, zinc, vitamin C, vitamin E, and essential fatty acids. This factor has a 
doubly negative effect and results from the fact that adolescents are still growing, 
and during pregnancy, nutrients compete with the fetus for development, therefore 
leading to nutritional deficiencies [31].
As to the studies recommended in pregnant adolescents to screen for preeclamp-
sia, there are currently no specific tests that can help establish a preclinical diagno-
sis, so the methods used in the general population are the only option:
1. First trimester combined test: markers (weight, blood pressure), ultrasound 
markers (uterine Doppler), and biochemical markers (PAPP-A, sFlt-1/PIGF).
Parra [38] Under 19 year 13.5% The prevalence is greater than 17–19  
years before the age of 17 p < 0.001
Zeck et al. [25] 5% in adolescents vs 1.5% in adults OR 3.666 (1.627, 7.723)
Tebeu et al. [24] Risk of 13–16 vs 20–34 years OR 2.974 (1.627, 5.427)
Gronvik [22] Meta-analysis OR 3.52 (2.26, 5.48)
Bostanci et al. [21] Age of  
resolution
P < 0.001
Number of 
appointments
P < 0.001
Prevalence of 
preeclampsia
P < 0.001
aOR
p < 0.001
Early adolescent
11–13 years
36 weeks 3.0 4.8% 1.14
(0.031, 0.63)
Middle 
adolescent
14–16 years
37 weeks 4.78
Late adolescent
17–19 years
38 weeks 5.54 2.7% 0.44
(0.31, 0.63)
Adult 5.9% 2.1
(1.51, 3.01)
Garmer [39] Hypertensive disorders related with pregnancy P = 0.99
<20 years 20–34 years
8.7% 9.2%
Azevedo et al. [6] Hypertensive disorders in pregnancy 10%
Table 2. 
Prevalences of preeclampsia in adolescents.
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2. Prophylactic aspirin before the 16th week of gestation in patients at greatest 
risk, based on an abnormal uterine Doppler in the first trimester.
3. In the second trimester, a uterine Doppler combined with other variables has a 
high negative predictive value.
Since there is no defined pattern in adolescent preeclampsia, its diagnosis and 
treatment must be the same as in the general population.
Therefore, the following recommendations have been established [32]:
In pregnant adolescents, screening, diagnostic, and therapeutic interventions 
should be similar to those applied in the rest of the population. Level of evidence, 
moderate. Recommendation, strong.
Care of pregnant adolescents must be provided in ex profeso clinics with com-
plete, integral, and multidisciplinary programs to decrease maternal and perinatal 
risks, including pregnancy-induced hypertension. Level of evidence, moderate. 
Recommendation, strong.
Although there is no evidence on the beneficial effect of interventions used 
to curb weight gain during pregnancy, offering a medical evaluation and nutri-
tional counseling is a good practice to recommend. Level of evidence, low. 
Recommendation, strong.
Every adolescent clinic must establish the incidence of preeclampsia and 
eclampsia in its patient population and determine which factors are associated to 
their development. Level of evidence, low. Recommendation, strong.
According to the diagnostic situation of preeclampsia and eclampsia in each 
adolescent clinic, screening, preventive, early detection, and therapeutic programs 
must be designed. Level of evidence, moderate. Recommendation, strong.
In adolescents with preeclampsia, the disease is generally manifested in the latter 
part of gestation, close to full-term delivery, so good prenatal care fosters a timely 
diagnosis of hypertensive disease in earlier stages and improves maternal and fetal 
outcomes. In the case of the induction of delivery, outcomes will also be improved 
by decreasing the need for cesarean delivery even in the cases of severe preeclamp-
sia: the neonatal outcome also improves since age is not an influencing factor but 
disease severity is.
8. Long-term fetal complications in hypertensive mothers
Follow-up of the offspring of mothers with any pregnancy-associated hyper-
tensive state [33] has shown that by age 7, their systolic blood pressure is increased 
although within normal parameters—SBP of 104 mm Hg (95%CI 101–106 vs. SBP 
99 mm Hg, 95%CI 99–100, p = 0.001)—and this cardiometabolic injury is evident 
from the age of 2 years.
This abnormality is only observed in full-term births and not in premature off-
spring; a posited explanation is that the stress caused by preterm delivery protects 
the fetus from sequelae.
Another consequence observed in the offspring of hypertensive mothers is the 
development of hypertension and cerebral vascular disease when these children 
reach adulthood. Also, their risk of developing hypertension increases if their body 
mass index is elevated, and this has been observed since the ages of 4–10, even if 
the mother had hypertension with no proteinuria; the presence of elevated liver 
enzymes or thrombocytopenia has also been associated with hypertension in young 
offspring [34, 35].
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Fetal changes due to maternal hypertension have been associated with genetic 
and environmental mechanisms that condition modifications in fetal program-
ming [36]. Among the effects caused by preeclampsia, one hypothesis suggests that 
superficial invasion of spiral arteries leads to fetal malnutrition. Changes in fetal 
programming may also involve abnormalities in the inflammatory response and 
endothelial dysfunction associated with preeclampsia.
An important point in this description of long-term sequelae in the offspring of 
pregnant adolescents is that they are not modified by age.
9. Points to remember
• Adolescent pregnancy is a very important biopsychosocial event, a public 
health issue, and a continuous social reflection.
• Hypertensive problem associated with pregnancy including the period of 
adolescence is another public health issue; its prevalence in the worldwide is 
around 10% of all pregnancies.
• Preeclampsia in adolescents refers to a relatively common hypertensive disor-
der during pregnancy that develops progressively. Its cause remains unknown, 
and it frequently leads to severe maternal and perinatal complications.
• The incidence is broad since it depends on various aspects such as geo-
graphic location, race, nutritional or immunological factors, and associated 
comorbidities.
• Traditional references accept that the risk of preeclampsia-eclampsia in 
adolescents is twice that in the adult population, but in recent studies 
including meta-analysis, the presence of preeclampsia in pregnant ado-
lescents varies from a 20% more frequent and specifically in the group of 
13–16 years (OR 2.97, 95% CI 1.62–5.42) to 23% less. Therefore, the available 
evidence suggests that adolescence is not a determining factor in the devel-
opment of preeclampsia and eclampsia, but geographic area does appear to 
be an additional factor.
• Two other determinants of risk factor for developing preeclampsia in pregnant 
adolescent are obesity and inadequate nutrient intake (calcium, zinc, vitamin 
C, vitamin E, and essential fatty acids).
• In adolescents with preeclampsia, the disease is generally manifested in the 
latter part of gestation, close to full-term delivery.
• A good prenatal care fosters timely diagnosis of hypertensive disease in earlier 
stages and improves maternal and fetal outcomes.
Prediction of Maternal and Fetal Syndrome of Preeclampsia
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